PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival

Overview
This study combined PM21-particles with IL-12/15/18 (CAP) to expand NK cells. CAP-NK cells showed superior expansion in G-Rex® 24, G-Rex® 6M, and G-Rex® 100M. The resulting cells exhibited memory-like properties, enhanced metabolic fitness, and improved in vivo persistence compared to PM21 alone.
What this paper found
Adding IL-12, IL-15 and IL-18 to PM21-particle stimulation (the CAP method) markedly increased ex vivo expansion of human NK cells from healthy-donor PBMC. Over 14 days, CAP-NK cells expanded a mean 8200-fold versus 1100-fold with PM21-particles alone, and doubled faster on day 9 (18 vs 27 h). In 24-well G-Rex® bioreactors left untouched for 7 days, CAP-NK cells expanded an average 41-fold versus 6-fold for PM21-NK cells, and two donors reached 11,500- and 10,800-fold by day 14 after transfer to larger G-Rex® formats. CAP-NK cells expressed more 4-1BB and CD25, killed SKOV-3 and A549 cancer cells more effectively, had higher basal glycolysis and maximal respiration, survived better without cytokines after a 7-day rest (85% vs 35% recovery) and persisted better in NSG mice.
Note: Preclinical study in cancer cell lines and NSG mice using healthy-donor NK cells; the 14-day scale-up into larger G-Rex® formats was carried out for two donors.
Taken as a whole, these data demonstrate that CAP-NK cells persist better, are cytotoxic after prolonged rest and exhibit memory-like responses upon restimulation. — Jeremiah L. Oyer, Tayler J. Croom-Perez, Md Faqrul Hasan, Javier A. Rivera-Huertas, Sarah B. Gitto, Joanna M. Mucha, Xiang Zhu, Deborah A. Altomare, Robert Y. Igarashi, Alicja J. Copik, Frontiers in Immunology
Study details
- Authors
- Jeremiah L. Oyer, Tayler J. Croom-Perez, Md Faqrul Hasan, Javier A. Rivera-Huertas, Sarah B. Gitto, Joanna M. Mucha, Xiang Zhu, Deborah A. Altomare, Robert Y. Igarashi, Alicja J. Copik
- Institution
- Burnett School of Biomedical Science, College of Medicine, University of Central Florida, Orlando, FL, United States
- Journal
- Frontiers in Immunology
- Year
- 2024
- G-Rex® model(s)
- G-Rex®100M, G-Rex®24 Well Plate, G-Rex®6M Well Plate
- Cell type(s)
- NK Cells
- Application area
- Hematologic malignancy · Solid tumor
- Study phase
- Preclinical
How G-Rex® was used
T-cell-depleted PBMC were seeded in G-Rex®24 (a 24-well G-Rex® bioreactor) with IL-2 and PM21-particles, with or without IL-12/15/18, and left untouched for 7 days; CAP-NK cells expanded an average 41-fold versus 6-fold for PM21-NK cells, with media glucose monitored from day 5. Cultures were then transferred to T-flasks, G-Rex®6M or G-Rex®100M and grown for another 7 days. For two donors, CAP cultures moved to a larger G-Rex® format reached 11,500- and 10,800-fold expansion by day 14.
Note: In the G-Rex® cultures, IL-12/15/18, PM21-particles and IL-2 were added together at the start without a cytokine wash step, unlike the overnight cytokine pre-activation followed by a wash used for the 14-day 8200-fold expansion.
Explore related
Full citation
Oyer JL, Croom-Perez TJ, Hasan MF, et al. PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival. Front Immunol. 2024;15:1383281.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.